Chinese english Germany Japanese Korea

tert-butyl 4-(3-cyclopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate

tert-butyl 4-(3-cyclopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate Struktur
2223036-77-7
CAS-Nr.
2223036-77-7
Englisch Name:
tert-butyl 4-(3-cyclopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate
Synonyma:
tert-butyl 4-(3-cyclopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate;1-Piperazinecarboxylic acid, 4-[3-cyclopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-, 1,1-dimethylethyl ester
CBNumber:
CB314363851
Summenformel:
C24H37BN2O4
Molgewicht:
428.37
MOL-Datei:
2223036-77-7.mol
Request For Quotation

tert-butyl 4-(3-cyclopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate Eigenschaften

Siedepunkt:
557.9±50.0 °C(predicted)
Dichte
1.13±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)
pka
3.19±0.20(predicted)

Sicherheit

tert-butyl 4-(3-cyclopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate Chemische Eigenschaften,Einsatz,Produktion Methoden

tert-butyl 4-(3-cyclopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

tert-butyl 4-(3-cyclopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Combiphos (Shanghai) Biological Technology Co., Ltd. 021-65232103 17602124823
 combiphos@vip.qq.com China 29909 58
  • tert-butyl 4-(3-cyclopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate
  • 1-Piperazinecarboxylic acid, 4-[3-cyclopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-, 1,1-dimethylethyl ester
  • 2223036-77-7
Copyright 2019 © ChemicalBook. All rights reserved